Factor affecting lymph node metastasis in uterine papillary serous carcinomas: a retrospective analysis

References

• Altay, A., et al., 2015. Analysis of metastatic regional lymph node locations and predictors of para-aortic lymph node involvement in endometrial cancer patients at risk for lymphatic dissemination. International Journal of Gynecological Cancer, 25 (4), 657–664.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists, 2005. ACOG Practice Bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstetrics and Gynecology, 106 (2), 413–425.
   PubMedGoogle Scholar
• ASTEC/EN.5 Study Group, et al., 2009. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet, 373 (9658), 137–146.
   PubMed Web of Science ®Google Scholar
• Baek, M.-H., et al., 2015. Identification of a preoperative predictive factor for lymph node metastasis in uterine papillary serous carcinoma: long-term results from a single institution. International Journal of Gynecological Cancer, 25 (1), 69–74.
   PubMed Web of Science ®Google Scholar
• Black, C., et al., 2016. Uterine papillary serous carcinoma: a single-institution review of 62 cases. International Journal of Gynecological Cancer, 26 (1), 133–140.
   PubMed Web of Science ®Google Scholar
• Bokhman, J.V., 1983. Two pathogenetic types of endometrial carcinoma. Gynecologic Oncology, 15 (1), 10–17.
   PubMed Web of Science ®Google Scholar
• Boruta, D.M., et al., 2009. Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review. Gynecologic Oncology, 115 (1), 142–153.
   PubMed Web of Science ®Google Scholar
• Boyraz, G., et al., 2017. Extrauterine spread, adjuvant treatment, and prognosis in noninvasive uterine papillary serous carcinoma of the endometrium: a retrospective multicenter study. International Journal of Gynecological Cancer, 27 (1), 102–108.
   PubMed Web of Science ®Google Scholar
• Carmen, M.G.d., Birrer, M., and Schorge, J.O., 2012. Uterine papillary serous cancer: a review of the literature. Gynecologic Oncology, 127 (3), 651–661.
   PubMed Web of Science ®Google Scholar
• Casarin, J., et al., 2020. Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma. Journal of Gynecologic Oncology, 31 (5), e64.
   PubMed Web of Science ®Google Scholar
• de Boer, S.M., et al., 2018. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. Lancet Oncology, 19 (3), 295–309.
   PubMed Web of Science ®Google Scholar
• Fader, A.N., et al., 2010. Uterine papillary serous carcinoma: epidemiology, pathogenesis and management. Current Opinion in Obstetrics & Gynecology, 22 (1), 21–29.
   PubMed Web of Science ®Google Scholar
• Feinberg, J., et al., 2019. Ten-year comparison study of type 1 and 2 endometrial cancers: risk factors and outcomes. Gynecologic and Obstetric Investigation, 84 (3), 290–297.
   PubMed Web of Science ®Google Scholar
• Garg, G., et al., 2013. The risk of lymph node metastasis with positive peritoneal cytology in endometrial cancer. International Journal of Gynecological Cancer, 23 (1), 90–97.
   PubMed Web of Science ®Google Scholar
• Hendrickson, M., et al., 1982. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. American Journal of Surgical Pathology, 6 (2), 93–108.
   PubMed Web of Science ®Google Scholar
• Kang, S., et al., 2014. A web-based nomogram predicting para-aortic nodal metastasis in incompletely staged patients with endometrial cancer: a Korean Multicenter Study. International Journal of Gynecological Cancer, 24 (3), 513–519.
   PubMed Web of Science ®Google Scholar
• Lax, S.F., 2016. New features in the 2014 WHO classification of uterine neoplasms. Der Pathologe, 37 (6), 500–511.
   PubMed Web of Science ®Google Scholar
• Kandoth, C., et al., 2013. Integrated genomic characterization of endometrial carcinoma. Nature, 497 (7447), 67–73.
   PubMed Web of Science ®Google Scholar
• Luomaranta, A., et al., 2014. Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinoma. International Journal of Gynecological Cancer, 24 (4), 697–702.
   PubMed Web of Science ®Google Scholar
• Mariani, A., et al., 2004. High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy. Gynecologic Oncology, 95 (1), 120–126.
   PubMed Web of Science ®Google Scholar
• Matsuo, K., et al., 2015. Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer. Journal of Surgical Oncology, 112 (6), 669–676.
   PubMed Web of Science ®Google Scholar
• Mattes, M.D., et al., 2015. The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry. Journal of Gynecologic Oncology, 26 (1), 19–24.
   PubMed Web of Science ®Google Scholar
• Olawaiye, A.B., et al., 2008. Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma. Gynecologic Oncology, 110 (3), 293–298.
   PubMed Web of Science ®Google Scholar
• Ørtoft, G., et al., 2019. Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study. Journal of Gynecologic Oncology, 30 (5), e84.
   PubMed Web of Science ®Google Scholar
• Qian, Y., et al., 2017. Extent of lymphovascular space invasion may predict lymph node metastasis in uterine serous carcinoma. Gynecologic Oncology, 147 (1), 24–29.
   PubMed Web of Science ®Google Scholar
• Roelofsen, T., et al., 2012a. Preoperative CA-125 predicts extra-uterine disease and survival in uterine papillary serous carcinoma patients. International Journal of Biological Markers, 27 (3), e263–e271.
   PubMed Web of Science ®Google Scholar
• Roelofsen, T., et al., 2012b. Pure compared with mixed serous endometrial carcinoma: two different entities? Obstetrics and Gynecology, 120 (6), 1371–1381.
   PubMed Web of Science ®Google Scholar
• Saga, Y., et al., 2006. Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus? Gynecologic Oncology, 103 (1), 277–280.
   PubMed Web of Science ®Google Scholar
• Sari, M.E., et al., 2017. Risk factors for paraaortic lymph node metastasis in endometrial cancer. International Journal of Clinical Oncology, 22 (5), 937–944.
   PubMed Web of Science ®Google Scholar
• Schmidt, M., et al., 2018. Cancer antigen 125 levels are significantly associated with prognostic parameters in uterine papillary serous carcinoma. International Journal of Gynecological Cancer, 28 (7), 1311–1317.
   PubMed Web of Science ®Google Scholar
• Semaan, A., et al., 2013. Clinical and pathologic characteristics of serous carcinoma confined to the endometrium: a multi-institutional study. International Journal of Gynecological Pathology, 32 (2), 181–187.
   PubMed Web of Science ®Google Scholar
• Solmaz, U., et al., 2016. Analysis of clinical and pathological characteristics, treatment methods, survival, and prognosis of uterine papillary serous carcinoma. Tumori, 102 (6), 593–599.
   PubMed Web of Science ®Google Scholar
• Suarez, A.A., Felix, A.S., and Cohn, D.E., 2017. Bokhman redux: endometrial cancer “types” in the 21st century. Gynecologic Oncology, 144 (2), 243–249.
   PubMed Web of Science ®Google Scholar
• Taskiran, C., et al., 2006. Predictability of retroperitoneal lymph node metastasis by using clinicopathologic variables in surgically staged endometrial cancer. International Journal of Gynecological Cancer, 16 (3), 1342–1347.
   PubMed Web of Science ®Google Scholar
• Todo, Y., et al., 2010. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet, 375 (9721), 1165–1172.
   PubMed Web of Science ®Google Scholar
• Turan, T., et al., 2011. Is it possible to predict para-aortic lymph node metastasis in endometrial cancer? European Journal of Obstetrics, Gynecology, and Reproductive Biology, 158 (2), 274–279.
   PubMed Web of Science ®Google Scholar
• Vaizoglu, F., et al., 2013. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer. Archives of Gynecology and Obstetrics, 288 (6), 1391–1397.
   PubMed Web of Science ®Google Scholar
• Winer, I., et al., 2015. Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence? International Journal of Gynecological Pathology, 34 (1), 47–56.
   PubMed Web of Science ®Google Scholar